Delivery Order SPE2DB24D2013-SPE2DB26FCGPR
Award Date 10/17/25
Potential Completion Date 10/20/25
Potential Value $3.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $5,770.97 delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL Vial 10mL, an insulin medication used in diabetes treatment. The contract was awarded on September 17, 2025, with an ultimate completion date of September 18, 2025, and represents a firm fixed price delivery order with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a $1,275.43 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL), an insulin product used in diabetes management. This firm fixed-price delivery order, with an ultimate completion date of August 13, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $5,309.82 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL Vial 10mL, an insulin medication used in diabetes treatment. The award was made on September 4, 2025, with a completion date of September 5, 2025, under a firm fixed-price contract with no set-aside designation. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,726.50 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10mL), an insulin medication used in diabetes management. The award was made on September 12, 2025, under a firm fixed-price contract type with an ultimate completion date of September 15, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. Performance will take place at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $3,463.19 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL Vial 10mL insulin on May 6, 2025, with completion scheduled for May 7, 2025. This delivery order represents a non-competitive, non-set-aside award under a firm fixed-price contract structure. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,944.90 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10mL units), an insulin product used in diabetes management. The award, issued on August 21, 2025, with completion targeted for August 22, 2025, utilizes firm fixed pricing with no small business set-aside. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order through its established...
- The Defense Logistics Agency awarded a $1,432.44 delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10 mL), an insulin medication commonly used for diabetes management. This firm fixed-price, competitively awarded contract was issued on June 5, 2025, with an ultimate completion date of June 6, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation, indicating it was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL), a rapid-acting insulin used for diabetes management. This competitively awarded, non-set-aside contract has a ceiling value of $12,920.59 and a firm fixed price structure, with an ultimate completion date of September 5, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $6,102.42 delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10mL) on July 30, 2025, with a completion date of July 31, 2025. This is a firm fixed price, non-set-aside contract to be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which...
- The Defense Logistics Agency awarded a delivery order valued at $2,765.03 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vial 10mL insulin medication on August 21, 2025, with completion scheduled for August 22, 2025. This competitive award, issued under firm fixed pricing terms, represents a routine pharmaceutical supply transaction supporting military healthcare operations. The award was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...